ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

 
Print Page
Email Article

New Research May Produce Better Pain-Relieving Treatments for Arthritis in Future

  [ 25 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 26, 2001


Researchers at Massachusetts General Hospital have shown for the first time how a class of common pain-relieving agents called nonsteroidal anti-inflammatory drugs (NSAIDs) – better known as aspirin and aspirin-like products – work by acting both within the central nervous system as well as in the inflamed region around the source of pain. Until now, it was thought that the effectiveness of these drugs was related to action at the inflammation site only.

The study, published in the March 22, 2001 issue of Nature, has important implications for improving the way that pain may be treated in the future and for developing safer, more effective pain-killing medications and delivery systems.

NSAIDs reduce inflammatory pain by blocking the action of certain enzymes called cyclooxygenase (Cox) 1 and 2. Cox-1 is normally expressed in the stomach, where it protects against acid damage, and in platelets, where it is involved in clotting. Cox-2, while not normally found in the skin or joints, is produced in these sites after inflammation occurs. Cox-2 is necessary in manufacturing a chemical called prostaglandin E2 (PGE2), which increases the sensitivity of nerves to pain. Inhibition of PGE2 at the site of inflammation had been thought to account for both the anti-inflammatory and pain-killing actions of NSAIDs. This 1970s discovery, in fact, earned a Nobel Prize for John Vane of London.

In the recent study, MGH researchers Clifford Woolf, MD, PhD, director of the Neural Plasticity Research Group in the Department of Anesthesia and Critical Care, Tarek Samad, PhD, a research fellow in Anesthesia, and their colleagues, showed that even as Cox-2 is produced at the site of inflammation, it also begins to be expressed in nerve cells in many regions of the spinal cord and brain. This previously unknown centralized expression results in the production of PGE2 throughout the central nervous system.

PGE2 increases the excitability of nerve cells, a phenomenon known as "central sensitization," which was discovered by Woolf in 1983. Central sensitization alters the processing of pain messages so that normally nonpainful stimuli such as moving a joint becomes painful, and a stimulus such as a pin prick becomes even more painful. It also explains the widespread tenderness that surrounds damaged or inflamed tissue.

"There clearly is a major central nervous system component in the way that the body responds to inflammation and this has a key role in the production of pain," says Woolf. "Now that we are starting to understand how local inflammation acts centrally, we need to go down a parallel track and find ways to manage pain hypersensitivity more effectively."

In the study, Woolf and his team also shed light on the complex pathway from inflammation to pain. The journey begins when peripheral inflammation stimulates production of a molecule called interleukin 1 beta (IL-1b). IL-1b acts as the trigger that signals nerve cells to switch on the Cox-2 gene. This expression of Cox-2 in turn causes the production of PGE2, which excites nerve cells and leads to pain.

Researchers determined that this chain of events could be interrupted at several points along the way to limit the sensation of pain. Drugs targeted at blocking production of IL-1b by inhibiting IL-1b-converting enzymes or ICE, as well as agents that inhibit Cox-2 expression can break this cycle and provide effective pain relief.

The researchers also found that because of the central nervous system involvement, drugs delivered directly into the spinal cord required significantly lower doses than drugs administered systemically.

Finally, the research team reported that data from the study indicate that the widespread presence of Cox-2 in the central nervous system may help address the question of why symptoms such as aches and pains, appetite loss and depression are often associated with infection and inflammation.

Woolf says that he is hopeful his team’s findings will help lead to faster, more effective pain-killing drugs that have fewer side effects. He points to last year’s introduction of two Cox-2 selective drugs, which have been highly successful "blockbuster" pain relievers, as the possible beginning of a new era in pain relief. These drugs are designed to achieve the analgesic benefits of aspirin and aspirin-like products without the well-known side effects of gastric irritation and bleeding that are associated with NSAIDs that inhibit both Cox-1 and Cox-2.

"We believe that to have the maximum efficacy, the next generation of pain killers will need to focus on inhibiting central as well as peripheral production of PGE2," Woolf says. "We’re tremendously excited about the potential to relieve suffering more effectively for millions of people around the world."

The study was funded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance
Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant Improvements in Memory, Learning, and Cognition.3 Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant Improvements in Memory, Learning, and Cognition.3
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map